Patients who died from liver failure had a substantially lower plasma AT-III level than those who died from HCC, although there was no significant difference in the Child–Pugh or albumin–bilirubin (ALBI) scores between the two groups. This evidence concerns the gene SERPINC1 and hepatocellular carcinoma.